1. Home
  2. AMPH vs MBIN Comparison

AMPH vs MBIN Comparison

Compare AMPH & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • MBIN
  • Stock Information
  • Founded
  • AMPH 1996
  • MBIN 1990
  • Country
  • AMPH United States
  • MBIN United States
  • Employees
  • AMPH N/A
  • MBIN N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • MBIN Major Banks
  • Sector
  • AMPH Health Care
  • MBIN Finance
  • Exchange
  • AMPH Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • AMPH 1.2B
  • MBIN 1.5B
  • IPO Year
  • AMPH 2014
  • MBIN 2017
  • Fundamental
  • Price
  • AMPH $24.39
  • MBIN $32.94
  • Analyst Decision
  • AMPH Buy
  • MBIN Buy
  • Analyst Count
  • AMPH 6
  • MBIN 3
  • Target Price
  • AMPH $35.50
  • MBIN $40.00
  • AVG Volume (30 Days)
  • AMPH 369.0K
  • MBIN 172.6K
  • Earning Date
  • AMPH 11-06-2025
  • MBIN 10-28-2025
  • Dividend Yield
  • AMPH N/A
  • MBIN 1.22%
  • EPS Growth
  • AMPH N/A
  • MBIN N/A
  • EPS
  • AMPH 2.68
  • MBIN 4.55
  • Revenue
  • AMPH $722,679,000.00
  • MBIN $598,079,000.00
  • Revenue This Year
  • AMPH $1.00
  • MBIN $4.04
  • Revenue Next Year
  • AMPH $6.74
  • MBIN $7.92
  • P/E Ratio
  • AMPH $9.15
  • MBIN $7.23
  • Revenue Growth
  • AMPH 1.37
  • MBIN N/A
  • 52 Week Low
  • AMPH $20.39
  • MBIN $27.25
  • 52 Week High
  • AMPH $53.96
  • MBIN $44.99
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 40.87
  • MBIN 57.52
  • Support Level
  • AMPH $22.94
  • MBIN $32.04
  • Resistance Level
  • AMPH $24.87
  • MBIN $33.04
  • Average True Range (ATR)
  • AMPH 0.79
  • MBIN 0.84
  • MACD
  • AMPH 0.12
  • MBIN 0.14
  • Stochastic Oscillator
  • AMPH 42.90
  • MBIN 96.01

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

Share on Social Networks: